Poster
CNS-Targeted Therapies Delivery Strategies and Sampling in Non-rodent Preclinical Species: Considerations During Early Phase Discovery to IND-Enabling Regulatory Studies
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs
Pragmatic Considerations for the Application of Physical Withdrawal Assessments in Patient Studies
Development of an Assay for Atropine in Rabbit Plasma by LC/MS/MS and the Impact of Atropine Esterase
The Sinclair Nanopigᵀᴹ—The Other Non-rodent
Sensitive Quantitation of Antisense Oligonucleotides Using Capitainer® qDBS Microsampling Device Coupled with Hybridization LC-MS/MS
Strategies to Improve Assay Sensitivity to Quantify Therapeutic Oligonucleotides
Singlicate Analysis in Ligand Binding Assays From Discovery to Regulated Clinical Studies: Implementation Strategies and Benefits
Collaborating for Success Tips for Improving Partnerships Between QA and Clinical Operations at Your Site
Risk-Based Auditing and its Application to GLP Computerized System Validation Procedures